Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Cancer|December 10, 2015
Genomic profiling of advanced bladder cancer to guide the use of targeted therapeuticsAngela K Green, Matthew I Milowsky
Cancer|August 6, 2014
Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?Arjun V Balar, Matthew I Milowsky
Current Opinion in Urology|June 16, 2015
Management of muscle-invasive bladder cancer in the elderlyTracy L Rose, Matthew I Milowsky
Current Treatment Options in Oncology|September 23, 2009
Bladder cancerDavid J Gallagher, Matthew I Milowsky
The Urologic Clinics of North America|September 5, 2003
Chemotherapeutic strategies for renal cell carcinomaMatthew I Milowsky, David M Nanus
The Urologic Clinics of North America|April 18, 2015
Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug developmentArjun V Balar, Matthew I Milowsky
Cancer Investigation|August 29, 2002
Estramustine plus a taxane for advanced prostate cancer: the new standard therapy?Matthew I Milowsky, David M Nanus
Cancer|May 31, 2013
Tools to improve clinical trial design in urothelial cancerAllison M Deal, Matthew I Milowsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The geriatrics and genetics behind bladder cancerMatthew I Milowsky, William Y Kim
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Novel agents in invasive urothelial cancerArjun V Balar, Matthew I Milowsky
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Cancer|December 10, 2015
Genomic profiling of advanced bladder cancer to guide the use of targeted therapeuticsAngela K Green, Matthew I Milowsky
Cancer|August 6, 2014
Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?Arjun V Balar, Matthew I Milowsky
Current Opinion in Urology|June 16, 2015
Management of muscle-invasive bladder cancer in the elderlyTracy L Rose, Matthew I Milowsky
Current Treatment Options in Oncology|September 23, 2009
Bladder cancerDavid J Gallagher, Matthew I Milowsky
The Urologic Clinics of North America|September 5, 2003
Chemotherapeutic strategies for renal cell carcinomaMatthew I Milowsky, David M Nanus
The Urologic Clinics of North America|April 18, 2015
Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug developmentArjun V Balar, Matthew I Milowsky
Cancer Investigation|August 29, 2002
Estramustine plus a taxane for advanced prostate cancer: the new standard therapy?Matthew I Milowsky, David M Nanus
Cancer|May 31, 2013
Tools to improve clinical trial design in urothelial cancerAllison M Deal, Matthew I Milowsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The geriatrics and genetics behind bladder cancerMatthew I Milowsky, William Y Kim
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Novel agents in invasive urothelial cancerArjun V Balar, Matthew I Milowsky
Pageof 21